Malignant glioma: current treatment perspectives.

Area of Science:

• Neuro-oncology
• Clinical Cancer Research

Background:

• Malignant gliomas require cytoreduction as a primary management goal.
• Multimodality therapy is central to treating these aggressive brain tumors.

Purpose of the Study:

• To outline the current standards of care for malignant gliomas.
• To highlight the role of clinical trials in advancing brain tumor treatment.

Main Methods:

• Review of existing medical, surgical, radiation, and chemotherapeutic approaches.
• Emphasis on clinical trials, including those from the Brain Tumor Cooperative Group.

Main Results:

• Cytoreduction via multimodality therapy is the established goal.
• Clinical trials are crucial for investigating novel therapeutic strategies.

Conclusions:

• Management of malignant gliomas involves a combination of therapies.
• Ongoing research through clinical trials is essential for improving patient outcomes.